Total Payments
$36,744
2024 Payments
$2,976
Companies
11
Transactions
23
Medicare Patients
1,480
Medicare Billing
$119,706
Payment Breakdown by Category
Consulting$34,680 (94.4%)
Food & Beverage$1,215 (3.3%)
Travel$804.39 (2.2%)
Research$44.55 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $34,680 | 7 | 94.4% |
| Food and Beverage | $1,215 | 13 | 3.3% |
| Travel and Lodging | $804.39 | 2 | 2.2% |
| Unspecified | $44.55 | 1 | 0.1% |
Payments by Type
General
$36,699
22 transactions
Research
$44.55
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $16,110 | 1 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $14,350 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $2,567 | 2 | $0 (2024) |
| Actelion Pharmaceuticals, Ltd | $1,815 | 2 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $865.55 | 7 | $0 (2017) |
| Edwards Lifesciences Corporation | $343.04 | 1 | $0 (2024) |
| Abbott Laboratories | $213.87 | 2 | $0 (2024) |
| Boston Scientific Corporation | $154.31 | 1 | $0 (2022) |
| Aidoc Medical Ltd | $131.00 | 1 | $0 (2023) |
| Sirtex Medical Inc | $125.13 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,976 | 4 | Novartis Pharmaceuticals Corporation ($2,450) |
| 2023 | $131.00 | 1 | Aidoc Medical Ltd ($131.00) |
| 2022 | $10,072 | 4 | E.R. Squibb & Sons, L.L.C. ($9,800) |
| 2021 | $1,770 | 1 | Actelion Pharmaceuticals, Ltd ($1,770) |
| 2020 | $20,660 | 3 | AstraZeneca Pharmaceuticals LP ($16,110) |
| 2019 | $99.77 | 1 | Abbott Laboratories ($99.77) |
| 2018 | $125.13 | 1 | Sirtex Medical Inc ($125.13) |
| 2017 | $910.10 | 8 | Actelion Pharmaceuticals US, Inc. ($865.55) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $114.10 | General |
| Category: Vascular | ||||||
| 09/04/2024 | Edwards Lifesciences Corporation | — | Travel and Lodging | In-kind items and services | $343.04 | General |
| 04/24/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| 04/07/2024 | Acarix USA Inc. | CADScor System (Device) | Food and Beverage | In-kind items and services | $69.08 | General |
| Category: Cardiology | ||||||
| 04/03/2023 | Aidoc Medical Ltd | BriefCase (Device) | Food and Beverage | Cash or cash equivalent | $131.00 | General |
| Category: medical device | ||||||
| 06/23/2022 | Boston Scientific Corporation | General - Therapies (Device) | Food and Beverage | In-kind items and services | $154.31 | General |
| Category: General - Therapies_IC | ||||||
| 04/02/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $117.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/21/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 01/14/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $8,400.00 | General |
| 02/01/2021 | Actelion Pharmaceuticals, Ltd | — | Consulting Fee | Cash or cash equivalent | $1,770.00 | General |
| 11/30/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: Cardiovascular | ||||||
| 11/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| Category: Cardiovascular | ||||||
| 09/14/2020 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $16,110.00 | General |
| 04/02/2019 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $99.77 | General |
| Category: Vascular | ||||||
| 03/18/2018 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $125.13 | General |
| Category: Interventional Oncology | ||||||
| 12/31/2017 | Actelion Pharmaceuticals, Ltd | — | — | In-kind items and services | $44.55 | Research |
| Study: RUBATO - AC-055H301 | ||||||
| 12/02/2017 | Actelion Pharmaceuticals US, Inc. | — | Travel and Lodging | Cash or cash equivalent | $461.35 | General |
| 12/02/2017 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $96.91 | General |
| 12/02/2017 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $75.38 | General |
| 12/02/2017 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $43.07 | General |
| 12/01/2017 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $84.98 | General |
| 12/01/2017 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $66.09 | General |
| 12/01/2017 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $37.77 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RUBATO - AC-055H301 | Actelion Pharmaceuticals, Ltd | $44.55 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 49 | 53 | $21,672 | $3,956 |
| 2021 | 8 | 421 | 650 | $260,567 | $57,000 |
| 2020 | 8 | 1,010 | 1,298 | $277,348 | $58,750 |
Total Patients
1,480
Total Services
2,001
Medicare Billing
$119,706
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 26 | $19,188 | $3,638 | 19.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 23 | 27 | $2,484 | $318.04 | 12.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 98 | 265 | $110,465 | $23,688 | 21.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 91 | 113 | $72,042 | $17,373 | 24.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 51 | 55 | $44,691 | $9,534 | 21.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 18 | $8,340 | $1,854 | 22.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 102 | 135 | $11,905 | $1,772 | 14.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 22 | 22 | $6,418 | $1,388 | 21.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 11 | $5,621 | $1,168 | 20.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 29 | 31 | $1,085 | $223.82 | 20.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 111 | 300 | $125,410 | $27,759 | 22.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 56 | 57 | $46,481 | $10,258 | 22.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 77 | 85 | $50,799 | $9,813 | 19.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 581 | 655 | $22,426 | $4,954 | 22.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 20 | 23 | $10,285 | $2,217 | 21.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 23 | 23 | $6,785 | $1,502 | 22.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 81 | 93 | $8,091 | $1,311 | 16.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 12 | $5,361 | $566.78 | 10.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2020 | 49 | 50 | $1,710 | $369.56 | 21.6% |
About Dr. Ami Bhatt, MD
Dr. Ami Bhatt, MD is a Internal Medicine healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285600155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ami Bhatt, MD has received a total of $36,744 in payments from pharmaceutical and medical device companies, with $2,976 received in 2024. These payments were reported across 23 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($34,680).
As a Medicare-enrolled provider, Bhatt has provided services to 1,480 Medicare beneficiaries, totaling 2,001 services with total Medicare billing of $119,706. Data is available for 3 years (2020–2022), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Boston, MA
- Active Since 02/28/2006
- Last Updated 08/24/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1285600155
Products in Payments
- ELIQUIS (Drug) $4,550
- General - Therapies (Device) $154.31
- BriefCase (Device) $131.00
- SIR-Spheres Microspheres (Device) $125.13
- LEQVIO (Drug) $117.22
- DRAGONFLY OPSTAR (Device) $114.10
- Mitra Clip system (Device) $99.77
- CADScor System (Device) $69.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boston
Michael Mendelsohn, M.d, M.D
Internal Medicine — Payments: $4.6M
Internal Medicine $4.6M
David Schenkein, Md, MD
Internal Medicine — Payments: $4.0M
Internal Medicine $4.0M
Dr. John Fallon, M.d, M.D
Internal Medicine — Payments: $2.5M
Internal Medicine $2.5M
Dr. David Scadden, Md, MD
Internal Medicine — Payments: $2.2M
Internal Medicine $2.2M
Dr. James Januzzi, Md, MD
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Dr. Marilyn Pike, Md Phd, MD PHD
Internal Medicine — Payments: $1.5M
Internal Medicine $1.5M